MarketWise, Inc. (MKTW)
NASDAQFinancialsFinancial - Data & Stock ExchangesSnapshot 2026-09-04
$18.64+2.59%
Close 2026-09-04 · 1-day change
NASDAQFinancialsFinancial - Data & Stock ExchangesSnapshot 2026-09-04
Intact: The reason to own it still holds.
MarketWise aims for $300M revenue in 2026. It plans $50M free cash flow. The company reauthorized a $50M stock buyback. These show growth and capital return focus.
MarketWise missed recent earnings and had negative cash flow in Q1. Management is volatile. Litigation and earnings misses raise risks.
The price is about 6% below our fair value near $21. Analysts expect 4% revenue growth. Our view is cautious due to recent misses.
Breaks if: Free cash flow remains negative or below $30 million in FY 2026
Breaks if: Revenue falls below $250 million in FY 2026
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround scenario with a focus on improving fundamentals. The current thesis state is cautious, as recent financial performance has been weak, and the company is under pressure from elevated risks.
The market appears to be pricing in an expensive valuation, reflecting weak execution quality and a fragile earnings outlook. There is an expectations gap, indicating that investors may be overly optimistic about future performance despite recent misses.
Management is on track to meet some key priorities, such as increasing billings and cash flow from operations. However, the recent financial performance has been weak, and the elevated risk of an earnings miss in the near term adds uncertainty.
The long-term thesis hinges on whether MKTW can maintain its billings and cash flow targets while navigating the risks of potential earnings misses. Additionally, the performance of sector bellwethers like SPGI, CME, and ICE will be crucial in determining the overall momentum for MKTW.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Continue to target full year billings growth with raised guidance to $330 million, a 21.7% increase over FY 2025.
Breaks if: Buyback program is canceled or not used at all in FY 2026
Over the next 1 to 3 years, MKTW's outlook will depend on its ability to stabilize its financial performance amid elevated risks and sector dynamics. Not investment advice.